x

Search for a diagnostic test

* (*) mandatory field

136 Result(s)

Filter by

Speciality(ies)/objective(s)

Technique(s)

Purpose(s)

Quality management

Country(ies)

Reset
Sort by

Caption : Accreditation =Accreditation
;

GERMANY

Nordrhein-Westfalen
DORTMUND

Accreditation
Diagnosis of myeloproliferative disorders (JAK2(V617F), MPL, TET2 genes)
Medizinisches Versorgungszentrum (MVZ) Dr. Eberhard und Partner
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

GERMANY

Niedersachsen
HANNOVER

Accreditation
Diagnosis of chronic myeloproliferative disorders (JAK2 gene: V617F)
Medizinische Hochschule Hannover
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing

GERMANY

Rheinland-Pfalz
INGELHEIM AM RHEIN

Accreditation
Diagnosis of chronic myeloproliferative disorders (JAK2 gene: mutation V617F)
Bioscientia Institut für Medizinische Diagnostik GmbH
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

GREECE

ATTIKI
ATHENS

Accreditation
Molecular diagnosis of myeloproliferative diseases : search for V617F mutation in JAK2 gene by ARMS-PCR
BioAnalytica-GenoType SA
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Technique(s) : PCR based techniques

GERMANY

Bayern
MARTINSRIED

Accreditation
Diagnosis of myeloproliferative disorders (JAK2 (exon 12, exon 14 (V617F)), MPL (exon 10), TET2 (exon 3-11) and PRV1 genes)
Zentrum für Humangenetik und Laboratoriumsdiagnostik (MVZ)
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

UNITED KINGDOM

South Yorkshire
SHEFFIELD

Accreditation
Molecular diagnosis of chronic myeloproliferative diseases (JAK2: by mutation analysis for V617F)
Sheffield Children's NHS Foundation Trust
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

GERMANY

Mecklenburg-Vorpommern
ROSTOCK

Accreditation
Diagnosis of chronic myeloproliferative disorders (JAK2 gene: mutation V617F)
Diagenom GmbH
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

FRANCE

ILE-DE-FRANCE
SAINT-OUEN-L'AUMÔNE

Accreditation
Diagnosis of myeloproliferative syndromes (V617F mutation in JAK2 gene)
Laboratoire Cerba
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing

GERMANY

Hamburg
HAMBURG

Accreditation
Diagnosis of chronic myeloproliferative disorders (JAK2 gene: V617F)
Labor Lademannbogen
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

UNITED KINGDOM

Devon
EXETER

Accreditation
Molecular diagnosis of myeloproliferative disorders (JAK2 gene)
Royal Devon and Exeter Hospital - Wonford site
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

FRANCE

GRAND-EST
COLMAR

Accreditation
Diagnosis of myeloproliferative syndromes (JAK2 gene : V617F mutation)
Hôpital Pasteur - Hôpitaux civils de Colmar
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

FRANCE

OCCITANIE
NÎMES

Accreditation
Diagnosis of chronic myeloproliferative disorders (JAK2 gene: V617F)
CHU de Nîmes - Hôpital Carémeau
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

FRANCE

ILE-DE-FRANCE
SAINT-MANDÉ

Accreditation
Diagnosis of chronic myeloproliferative disorders (JAK2 gene)
Hôpital d'Instruction des Armées Bégin
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

UNITED KINGDOM

Avon
BRISTOL

Accreditation
Molecular haemato-oncology diagnosis of myeloproliferative syndromes (JAK2 gene: V617F mutation and exon 12 analysis)
Southmead Hospital
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

FRANCE

GRAND-EST
METZ

Accreditation
Diagnosis of myeloproliferative diseases (JAK gene: V617F mutation)
CHR de Metz-Thionville
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : Sanger sequencing

GERMANY

Sachsen
DRESDEN

Accreditation
Diagnosis of chronic myeloproliferative disorders (JAK2 gene)
MVZ Mitteldeutscher Praxisverbund Humangenetik GmbH
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

UNITED KINGDOM

Grampian
ABERDEEN

Accreditation
Molecular diagnosis of Myeloproliferative disorders (JAK2 gene)
Aberdeen Royal Infirmary, Polwarth Building
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

SWITZERLAND

Suisse Romande
SION

Accreditation
Diagnosis of variants associated with myeloproliferative syndromes (panel)
Institut Central des Hôpitaux (ICH)
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES)

GERMANY

Nordrhein-Westfalen
DORTMUND

Accreditation
Diagnosis of acute myeloid leukemia
Medizinisches Versorgungszentrum (MVZ) Dr. Eberhard und Partner
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics, Cytogenetics, Immunology
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Detection of chromosome alterations large in size, Detection of microdeletions/microduplications
Technique(s) : Sanger sequencing, PCR based techniques, FISH, Karyotyping

UNITED KINGDOM

West Midlands
BIRMINGHAM

Accreditation
Molecular diagnosis of myeloproliferative disorders (JAK2 gene: V617 mutation)
Birmingham Women's NHS Foundation Trust
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

UNITED KINGDOM

Wiltshire
SALISBURY

Accreditation
Molecular diagnosis of Myeloproliferative disorders (JAK2 gene:mutation V617F: ARMSPCR and pyrosequencing, 9q24)
Salisbury District Hospital
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Technique(s) : PCR based techniques

GERMANY

Bayern
MARTINSRIED

Accreditation
Diagnosis of chronic myeloproliferative disorders (TET2 gene (exon 3-11), JAK2 gene (V617F), TP53 (exon 4-9))
Zentrum für Humangenetik und Laboratoriumsdiagnostik (MVZ)
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : Sanger sequencing

GERMANY

Baden-Württemberg
TÜBINGEN

Accreditation
Diagnosis of chronic myeloproliferative disorders (JAK2 gene)
CeGaT GmbH
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

GERMANY

Baden-Württemberg
TÜBINGEN

Accreditation
Diagnosis of Budd-Chiari syndrome (JAK2 gene)
CeGaT GmbH
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

AUSTRIA

WIEN
WIEN

Accreditation
Molecular diagnosis of myeloproliferative syndromes (JAK2 gene: V617F mutation, sequencing of exon 12; CALR gene exon 9)
Medizinische Universität Wien
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : Sanger sequencing, PCR based techniques

FRANCE

CENTRE-VAL DE LOIRE
CHAMBRAY-LES-TOURS

Accreditation
Diagnosis of myeloproliferative disorders (JAK2 gene)
SELAS Arnaud-Biolys-Origet
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

GERMANY

Hamburg
HAMBURG

Accreditation
Diagnosis of Budd-Chiari syndrome (JAK2 gene)
MVZ Fenner & Krasemann
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

GERMANY

Hamburg
HAMBURG

Accreditation
Diagnosis of chronic myeloproliferative disorders (JAK2 gene)
MVZ Fenner & Krasemann
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

UNITED KINGDOM

Cambridgeshire
CAMBRIDGE

Accreditation
Molecular and molecular cytogenetic diagnosis of Myeloproliferative neoplasm (BCR/ABL1, JAK2 (V617F and exon 12 mut), MPL (S505 and W515 mut), FIP1L1/PDGFRA
Cambridge University Hospitals NHS Foundation Trust
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics, Cytogenetics

ITALY

VENETO
PADOVA

Accreditation
Molecular diagnosis of myeloproliferative diseases (JAK2 gene)
Azienda Ospedaliera di Padova
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

GERMANY

Baden-Württemberg
FREIBURG

Accreditation
Diagnosis of Budd-Chiari syndrome (JAK2 gene)
Synlab MVZ Freiburg GmbH
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

SPAIN

Cataluña
L'HOSPITALET DE LLOBREGAT

Accreditation
Diagnosis of thrombocytopenia related disorders (gene panel)
Reference Laboratory Genetics
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing

CANADA

Ontario
MISSISSAUGA

Accreditation
Molecular Diagnosis of Myeloproliferative Disorder
Trillium Health Partners- Credit Valley Site
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

GERMANY

Baden-Württemberg
TÜBINGEN

Accreditation
Diagnosis of familial thrombocytosis (JAK2, MPL genes)
CeGaT GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

SPAIN

Cataluña
L'HOSPITALET DE LLOBREGAT

Accreditation
Diagnosis of polycythemia vera (JAK2 gene)
Reference Laboratory Genetics
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : Sanger sequencing, PCR based techniques

SPAIN

Cataluña
L'HOSPITALET DE LLOBREGAT

Accreditation
Diagnosis of myeloproliferative neoplasm (gene panel)
Reference Laboratory Genetics
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing

FRANCE

ILE-DE-FRANCE
PARIS

Accreditation
Diagnosis of predisposition to hemopathies (Panel)
CHU Paris - Hôpital Robert Debré
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES)

FRANCE

PAYS DE LA LOIRE
NANTES

Accreditation
Diagnosis of polycythemia (Panel)
CHU de Nantes - Institut de Biologie
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing

GERMANY

Bayern
MÜNCHEN

Accreditation
Diagnosis of familial thrombocytosis (JAK2, MPL, THPO genes)
Pränatal-Medizin München MVZ GmbH
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis, Pre-symptomatic diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

AUSTRIA

OBERÖSTERREICH
LINZ

Accreditation
Molecular diagnosis of myoproliferative neoplasms (JAK2, CALR, MPL, CSF3R, and SETBP1 genes)
Ordensklinikum Linz GmbH Barmherzige Schwestern
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : Sanger sequencing

SPAIN

Cataluña
L'HOSPITALET DE LLOBREGAT

Accreditation
Diagnosis of aplastic anemia and related disorders (gene panel)
Reference Laboratory Genetics
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

GERMANY

Bayern
MÜNCHEN

Accreditation
Diagnosis of primary myelofibrosis (JAK2 gene)
Pränatal-Medizin München MVZ GmbH
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

FRANCE

GRAND-EST
VANDOEUVRE-LÈS-NANCY

Accreditation
Diagnosis of myeloproliferative syndromes (V617F mutation in JAK2,CALR and MPL genes)
CHU de Nancy - Hôpitaux de Brabois
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

GERMANY

Baden-Württemberg
TÜBINGEN

Accreditation
Molecular analysis of somatic mutation in tumour tissue for therapeutic decisions (Somatic Tumor Panel, 710 genes)
CeGaT GmbH
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

NETHERLANDS

Utrecht
UTRECHT

Accreditation
Molecular diagnosis of Primary Immunodeficiency (gene panel; PID00v17.1)
UMC Utrecht - Universitair Medisch Centrum Utrecht
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

GERMANY

Baden-Württemberg
TÜBINGEN

Accreditation
Diagnosis of hematopoietic defects (NGS screening panel: 183 genes)
CeGaT GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

FRANCE

ILE-DE-FRANCE
CRÉTEIL

Accreditation
Diagnosis of congenital polycythemia (Panel)
Hôpitaux Universitaires Henri Mondor
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES)

FRANCE

ILE-DE-FRANCE
PARIS

Accreditation
Diagnosis of myeloproliferative syndromes (JAK2 gene)
Groupe Hospitalier Paris Saint-Joseph
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

FRANCE

GRAND-EST
VANDOEUVRE-LÈS-NANCY

Accreditation
Diagnosis of myeloid hemopathy (Panel)
CHU de Nancy - Hôpitaux de Brabois
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

FRANCE

GRAND-EST
VANDOEUVRE-LÈS-NANCY

Accreditation
Diagnosis of intellectual disability and/or epilepsy (Panel)
CHU de Nancy - Hôpitaux de Brabois
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Whole Exome Sequencing (WES)

FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

Accreditation
Diagnosis of rare red blood cell enzymopathies and membranopathies (Panel)
CHU de Marseille - Hôpital de la Timone
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing

BELGIUM

LIEGE
LIEGE

Accreditation
Diagnosis of chronic myeloproliferative disorders (JAK2 gene: V617F mutation in exon 14)
CHU de Liège - UniLab Lg
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

BELGIUM

LIEGE
LIEGE

Accreditation
Diagnosis of polycythemia vera (JAK2 gene : detection of rare mutations in exon 12)
CHU de Liège - UniLab Lg
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : Sanger sequencing

GERMANY

Baden-Württemberg
ULM

Accreditation
Diagnosis of chronic myeloproliferative disorders (JAK2 gene)
DRK Baden-Württemberg/ Hessen
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

GERMANY

Bayern
MARTINSRIED

Accreditation
Diagnosis of acute myeloid leukemia (FLT3 gene: ITD and D835, JAK2 gene: V617F/G1849T, NPM1 gene: exon 12, t(8; 21), t(15; 17), inv(16))
LabPMM GmbH
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : Sanger sequencing

CANADA

Ontario
TORONTO

Accreditation
Molecular Diagnosis of Myeloproliferative Disorder (JAK2 V617F, CALR targeted mutation analysis)
Toronto General Hospital
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

CANADA

Terre-Neuve-et-Labrador
ST. JOHN'S

Accreditation
Molecular Diagnosis of Myeloproliferative Disorder (JAK2 V617F mutation analysis)
Health Sciences Centre
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

CANADA

Ontario
LONDON

Accreditation
Molecular Diagnosis of Myeloproliferative Disorder (JAK2 V617F targeted mutation analysis)
London Health Sciences Centre
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

CANADA

Ontario
HAMILTON

Accreditation
Molecular Diagnosis of Myeloproliferative Neoplams (JAK2 exon 12, V617F, MPL515 targeted mutation)
McMaster University Medical Centre
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

FRANCE

ILE-DE-FRANCE
PARIS

Accreditation
Diagnosis of myelodysplastic syndrome and myelodysplastic acute leukemia (Panel)
CHU Paris-GH St-Louis Lariboisière F.Widal - Hôpital Saint-Louis
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, PCR based techniques

FRANCE

OCCITANIE
TOULOUSE

Accreditation
Diagnosis of myeloproliferative syndromes (V617F mutation in JAK2 gene)
IUCT Oncopole - CHU Toulouse
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

FRANCE

ILE-DE-FRANCE
PARIS

Accreditation
Diagnosis of primary immunodeficiency (Panel)
Hôpital Necker-Enfants Malades
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

ITALY

VENETO
VERONA

Molecular diagnosis of myeloid leukemias (BCR, ABL1, JAK2, PML, RARA, AML1 and ETO genes)
Azienda Ospedaliera Universitaria Integrata di Verona - Ospedale Borgo Roma
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

SPAIN

Comunidad Valenciana
PATERNA

Diagnosis of myeloproliferative neoplasm (JAK2 gene / p.V617F mutation)
Sistemas Genómicos S.L.
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

FRANCE

ILE-DE-FRANCE
CRÉTEIL

Diagnosis of myeloproliferative syndromes (JAK2 gene : V617F mutation ; TET2)
Hôpitaux Universitaires Henri Mondor
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : Sanger sequencing

GERMANY

Niedersachsen
OSNABRÜCK

Diagnosis of Budd-Chiari syndrome (F5, JAK2 genes)
Praxis Dres. Gencik
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

TURKEY

TURKEY
ISTANBUL

Molecular diagnosis of chronic myeloproliferative syndromes (JAK2 gene)
Genetiks - Genetic diagnosis and research center
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

GERMANY

Mecklenburg-Vorpommern
ROSTOCK

Diagnosis of Budd-Chiari syndrome (F5 gene: sequencing; JAK2 gene:sequencing / MLPA)
Centogene AG
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

GERMANY

Mecklenburg-Vorpommern
ROSTOCK

Diagnosis of chronic myeloproliferative disorders (JAK2 gene: sequencing / MLPA)
Centogene AG
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

SPAIN

Madrid
SAN SEBASTIÁN DE LOS REYES

Diagnosis of polycythemia vera (JAK2 gene - V617F, K539L, V607N mutations)
LabGenetics - Laboratorio de Genética Clínica, S.L.
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis, Pre-symptomatic diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

SPAIN

Madrid
SAN SEBASTIÁN DE LOS REYES

Diagnosis of essential thrombocythemia (CALR, MPL, JAK2 genes)
LabGenetics - Laboratorio de Genética Clínica, S.L.
Purpose(s) : Antenatal diagnosis, Pre-symptomatic diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

SPAIN

País Vasco
SAN SEBASTIÁN

Diagnosis of polycythemia vera (JAK2 gene)
DNA Data
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing

SPAIN

País Vasco
SAN SEBASTIÁN

Diagnosis of myelofibrosis with myeloid metaplasia (JAK2 gene / mutation V617F/G1849T)
Hospital Universitario Donostia
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

SPAIN

País Vasco
SAN SEBASTIÁN

Diagnosis of polycythemia vera (JAK2 gene / mutation V617F/G1849T)
Hospital Universitario Donostia
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

SPAIN

País Vasco
SAN SEBASTIÁN

Diagnosis of essential thrombocythemia (JAK2 gene / mutation V617F/G1849T)
Hospital Universitario Donostia
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

POLAND

Bydgoszcz
BYDGOSZCZ

Molecular diagnosis of myeloproliferative syndromes (V617F mutation in JAK2 gene)
Szpital Uniwersytecki im. dr. Antoniego Jurasza
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

ITALY

FRIULI VENEZIA GIULIA
UDINE

Molecular diagnosis of polycythemia vera (JAK2 gene)
Azienda Ospedaliero-Universitaria "Santa Maria della Misericordia" di Udine
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

ITALY

FRIULI VENEZIA GIULIA
UDINE

Molecular diagnosis of thrombocythemia (JAK2, MPL genes)
Azienda Ospedaliero-Universitaria "Santa Maria della Misericordia" di Udine
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

SPAIN

Comunidad Valenciana
PATERNA

Diagnosis of polycythemia vera (JAK2 gene)
IMEGEN - Delegación Valencia
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : Sanger sequencing, PCR based techniques

SPAIN

La Rioja
LOGROÑO

Diagnosis of polycythemia vera (JAK2 gene / V617F mutation)
Fundación Rioja Salud - Centro de Investigación Biomédica de La Rioja
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing

GERMANY

Baden-Württemberg
STUTTGART

Diagnosis of chronic myeloproliferative disorders (JAK2 gene)
Klinikum Stuttgart - Standort Olgahospital
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

SPAIN

Comunidad Valenciana
ALICANTE

Diagnosis of polycythemia vera (JAK2 gene)
Hospital Clínica Vistahermosa
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : Sanger sequencing, PCR based techniques

ITALY

SICILIA
AVOLA

Diagnosis of myelofibrosis with myeloid metaplasia (JAK2 gene)
Laboratori Campisi s.r.l.
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

SPAIN

Cataluña
TARRAGONA

Diagnosis of myelofibrosis with myeloid metaplasia (JAK2 gene / mutation V617F; CALR gene / mutations in exon 9)
Hospital Universitari de Tarragona Joan XXIII
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

SPAIN

Cataluña
TARRAGONA

Diagnosis of polycythemia vera (JAK2 gene / mutation V617F)
Hospital Universitari de Tarragona Joan XXIII
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

SPAIN

Cataluña
TARRAGONA

Diagnosis of essential thrombocythemia (JAK2, CALR genes)
Hospital Universitari de Tarragona Joan XXIII
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

ITALY

BASILICATA
MATERA

Postnatal molecular diagnosis of myeloproliferative syndromes (V617F mutation in JAK2 gene)
Presidio Ospedaliero "Madonna delle Grazie" - Azienda Sanitaria di Matera (ASM)
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

ITALY

LOMBARDIA
VARESE

Molecular diagnosis of myeloproliferative neoplasm (JAK2 gene)
A.O.U. Ospedale di Circolo e Fondazione Macchi - Università dell'Insubria
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : NGS sequencing (except WES)

ITALY

LOMBARDIA
SAN FERMO DELLA BATTAGLIA

Molecular diagnosis of essential thrombocythemia (CALR and JAK2 genes)
ASST Lariana - Ospedale S.Anna di Como
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

ITALY

LOMBARDIA
SAN FERMO DELLA BATTAGLIA

Molecular diagnosis of polycythemia vera (JAK2 gene)
ASST Lariana - Ospedale S.Anna di Como
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

ITALY

LOMBARDIA
SAN FERMO DELLA BATTAGLIA

Molecular diagnosis of primary myelofibrosis (CALR and JAK2 genes)
ASST Lariana - Ospedale S.Anna di Como
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

AUSTRIA

WIEN
WIEN

Molecular diagnosis of chronic myeloproliferative disorders (JAK2 gene)
Medizinische Universität Wien
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

SPAIN

La Rioja
LOGROÑO

Diagnosis of myeloproliferative neoplasm (CALR, JAK2 (exon 12), MPL genes)
Hospital San Pedro
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : Sanger sequencing, PCR based techniques

SPAIN

Madrid
SAN SEBASTIÁN DE LOS REYES

Diagnosis of primary myelofibrosis (JAK2 gene)
LabGenetics - Laboratorio de Genética Clínica, S.L.
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

AUSTRIA

WIEN
WIEN

Diagnosis of myelodysplastic/myeloproliferative diseases (analysis block: ASXL1, CBL, DNMT3A, ETV6, EZH2, IDH1, IDH2, JAK2, KRAS, NRAS, RUNX1, SF3B1, SRSF2, TET2, TP53, U2AF1, ZRSR2 gene)
Hanusch Krankenhaus
Purpose(s) : Somatic genetics, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

AUSTRIA

WIEN
WIEN

Diagnosis of myeloproliferative neoplasms (analysis block: ASXL1, CALR, CBL, CSF3R, EZH2, IDH1, IDH2, JAK2, MPL, SETBP1, SF3B1, SRSF2 gene; single gene analyses: CALR, JAK2 V617F mutation)
Hanusch Krankenhaus
Purpose(s) : Post-natal diagnosis, Somatic genetics, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

SPAIN

Comunidad Valenciana
VALENCIA

Diagnosis of solid tumors (panel)
INCLIVA - Facultad de Medicina de la Universidad de Valencia
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : NGS sequencing (except WES)

SPAIN

Cataluña
BARCELONA

Diagnosis of primary immunodeficiency (panel)
Hospital Universitari Vall d'Hebron
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis, Pre-symptomatic diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

SPAIN

Comunidad Valenciana
VALENCIA

Diagnosis of selection of therapeutic option in non-small cell lung carcinoma (panel)
Fundación Hospital General Universitario de Valencia
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

PORTUGAL

CENTRO
COIMBRA

Molecular diagnosis of polycythemia vera (JAK2 gene): exon 12 sequencing.
Hosp. Pediátrico e Hosp. Covões - Centro Hospitalar e Universitário de Coimbra
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

CZECH REPUBLIC

South Moravia
BRNO

Molecular diagnosis of myeloproliferative neoplasms (JAK2 gene)
University hospital Brno
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

UNITED KINGDOM

Greater Manchester
MANCHESTER

Molecular diagnosis of Polycythaemia Vera, Essential Thrombocythaemia and Idiopathic Myelofibrosis by JAK2 analysis
Manchester University NHS Foundation Trust - Manchester Royal Infirmary
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

ITALY

PUGLIA
SAN GIOVANNI ROTONDO

Molecular diagnosis of polycythemia vera (JAK2 gene)
IRCCS Ospedale Casa Sollievo della Sofferenza -Poliamb. Giovanni Paolo II
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

ITALY

PUGLIA
SAN GIOVANNI ROTONDO

Diagnosis of essential thrombocythemia (analysis of JAK2, MPL exon 10 and CALR exon 9 genes)
IRCCS Ospedale Casa Sollievo della Sofferenza -Poliamb. Giovanni Paolo II
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

ITALY

PUGLIA
SAN GIOVANNI ROTONDO

Molecular diagnosis of myelofibrosis with myeloid metaplasia (JAK2 gene)
IRCCS Ospedale Casa Sollievo della Sofferenza -Poliamb. Giovanni Paolo II
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

ITALY

PUGLIA
SAN GIOVANNI ROTONDO

Molecular diagnosis of acute myeloblastic leukaemia (JAK2 gene)
IRCCS Ospedale Casa Sollievo della Sofferenza -Poliamb. Giovanni Paolo II
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

ITALY

CALABRIA
REGGIO CALABRIA

Molecular diagnosis of polycythemia vera (JAK2 gene)
Azienda Ospedaliera BMM
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

ITALY

CALABRIA
REGGIO CALABRIA

Molecular diagnosis of essential thrombocythemia (JAK2 gene)
Azienda Ospedaliera BMM
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

ITALY

CALABRIA
REGGIO CALABRIA

Molecular diagnosis of myelofibrosis with myeloid metaplasia (JAK2 gene)
Azienda Ospedaliera BMM
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

ITALY

CALABRIA
REGGIO CALABRIA

Molecular diagnosis of acute myeloblastic leukaemia (JAK2 gene)
Azienda Ospedaliera BMM
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

LEBANON

Beyrouth
BEIRUT

Molecular diagnosis of myeloproliferative syndromes (V617F mutation of JAK2 gene)
Université Saint-Joseph
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

ROMANIA

CLUJ
CLUJ-NAPOCA

Molecular diagnosis of chronic myeloproliferative diseases (V617F mutation of JAK2 gene)
Spitalul Judetean Clinc de Urgenta Cluj
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

SLOVENIA

SLOVENIA
LJUBLJANA

Molecular diagnosis of chronic myeloproliferative disorders (JAK2 gene: V617F mutation)
University Medical Center Ljubljana
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

SERBIA

Serbia
BELGRADE

Molecular diagnosis of chronic myeloproliferative disorders (JAK2 gene: mutation V617F)
Institute of Molecular Genetics and Genetic Engineering
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

FRANCE

PROVENCE-ALPES-COTE D'AZUR
NICE

Diagnosis of myeloproliferative syndromes (JAK2 gene: V617F mutation)
CHU de Nice - Hôpital Pasteur
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

ITALY

LOMBARDIA
LODI

Molecular diagnosis of polycythemia vera (JAK2 gene)
Azienda Ospedaliera della Provincia di Lodi
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

ITALY

LOMBARDIA
BRESCIA

Molecular diagnosis of myeloproliferative diseases (JAK2 gene)
Biodiversity
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

CZECH REPUBLIC

Moravia-Silesia
OSTRAVA

Molecular diagnosis of polycythemia vera (JAK2 gene)
CGB laboratory Ltd.
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

LITHUANIA

DZUKIJA
VILNIUS

Molecular diagnosis of myeloproliferative disorders (JAK2 gene:mutation V617F)
Vilnius University Hospital Santariskiu Klinikos
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

CZECH REPUBLIC

Olomouc
OLOMOUC

Molecular diagnosis of myeloproliferative disorders (JAK2 gene)
University hospital Olomouc
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

CZECH REPUBLIC

South Bohemia
CESKE BUDEJOVICE

Molecular diagnosis of myeloproliferative disorders (JAK2 gene)
Hospital Ceské Budejovice
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

PORTUGAL

CENTRO
COIMBRA

Molecular diagnosis of Polycythaemia Vera, Essential Thrombocythaemia and Idiopathic Myelofibrosis (JAK2 gene): V617F mutation and exon 14 quantification (RT-PCR).
Hosp. Pediátrico e Hosp. Covões - Centro Hospitalar e Universitário de Coimbra
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Technique(s) : PCR based techniques

POLAND

Warszawa
WARSAW

Molecular diagnosis of myeloproliferative syndromes (V617F mutation in JAK2 gene)
IHIT Instytut Hematologii I Transfuzjologii
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics

AUSTRIA

WIEN
WIEN

Molecular diagnosis of susceptibility to Budd-Chiari syndrome (F5 and JAK2 genes)
Praxis für Humangenetik
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

SPAIN

Galicia
A CORUÑA

Diagnosis of chronic myeloproliferative disorders (ABL1, BCR, JAK2 genes)
Hospital Universitario da Coruña
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics, Cytogenetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Detection of chromosome alterations large in size
Technique(s) : PCR based techniques, Karyotyping

FRANCE

BRETAGNE
RENNES

Diagnosis of myeloproliferative neoplasm (JAK2 gene by PCR, QPCR)
CHU de Rennes - Hôpital Pontchaillou
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Technique(s) : PCR based techniques

FRANCE

NOUVELLE AQUITAINE
PESSAC

Diagnosis of chronic myeloproliferative disorders (V617F detection and exon 12 sequencing of JAK2 gene)
CHU de Bordeaux-GH Sud - Hôpital Haut-Lévêque
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : Sanger sequencing, PCR based techniques

FRANCE

GRAND-EST
VANDOEUVRE-LÈS-NANCY

Diagnosis of hepatic diseases (Panel)
CHU de Nancy - Hôpitaux de Brabois
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

AUSTRIA

WIEN
WIEN

Molecular diagnosis of essential thrombocythemia (JAK2 and TP53 genes)
Praxis für Humangenetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

GERMANY

Berlin
BERLIN

Diagnosis of chronic myeloproliferative disorders (JAK2 gene: V617F)
IFLb Laboratoriumsmedizin Berlin GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

SPAIN

Cataluña
BADALONA

Diagnosis of polycythemia vera (JAK2 gene / V617F mutation)
ICO Badalona - Hospital Germans Trias i Pujol
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

SPAIN

Cataluña
BADALONA

Diagnosis of essential thrombocythemia (CALR gene / exon 9; MPL gene / exon 10; JAK2 gene / V617F mutation)
ICO Badalona - Hospital Germans Trias i Pujol
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : Sanger sequencing, PCR based techniques

SPAIN

Cataluña
BADALONA

Diagnosis of primary myelofibrosis (CALR gene / exon 9; MPL gene / exon 10; JAK2 gene / V617F mutation)
ICO Badalona - Hospital Germans Trias i Pujol
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : Sanger sequencing, PCR based techniques

SPAIN

Cataluña
BADALONA

Diagnosis of myeloid hemopathy (panel)
ICO Badalona - Hospital Germans Trias i Pujol
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

SPAIN

Madrid
MADRID

Diagnosis of myeloproliferative neoplasm (JAK2 gene / V617F, exon 12; CALR gene; MPL gene / W515 W505)
Hospital General Universitario Gregorio Marañón
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : Sanger sequencing, PCR based techniques

SPAIN

Madrid
MADRID

Diagnosis of myeloid hemopathy (panel)
Hospital General Universitario Gregorio Marañón
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES)